Xuefang Liu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 14
-
- Traditional Chinese Medicine Analysis 8
- Pharmacology top 5%
- Molecular Biology top 10%
- RNA modifications and cancer 8
- Circular RNAs in diseases 7
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 12
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
-
- Pediatric health and respiratory diseases 7
-
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Xuefang Liu
101 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 131
- Cancer Research 441
- Complementary and alternative medicine 120
- Pharmacology 113
- Molecular Biology 737
- Pulmonary and Respiratory Medicine 283
Countries citing papers authored by Xuefang Liu
This map shows the geographic impact of Xuefang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefang Liu more than expected).
Fields of papers citing papers by Xuefang Liu
This network shows the impact of papers produced by Xuefang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefang Liu. The network helps show where Xuefang Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xuefang Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 6 | |
| 10 | 2022 | 26 | |
| 11 | 2021 | 30 | |
| 12 | 2020 | 9 | |
| 13 | 2020 | 14 | |
| 14 | 2019 | 1 | |
| 15 | 2018 | 33 | |
| 16 | 2018 | 11 | |
| 17 | 2018 | 86 | |
| 18 | 2018 | 3 | |
| 19 | 2017 | 15 | |
| 20 | 2010 | 19 |
About Xuefang Liu
Xuefang Liu is a scholar working on Complementary and alternative medicine, Life-span and Life-course Studies and Cancer Research, having authored 109 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (12 papers), RNA modifications and cancer (8 papers), Traditional Chinese Medicine Analysis (8 papers), Pediatric health and respiratory diseases (7 papers), Circular RNAs in diseases (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers). The work is most often cited by research in Cancer Research (441 citations), Complementary and alternative medicine (120 citations) and Pharmacology (113 citations). Xuefang Liu has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Jiansheng Li, Peng Zhao, Suxiang Feng, Yange Tian, Jiancheng Tu, Ping Luo, Yanqin Qin, Xiaobo Feng, Chunzi Liang and Jing Wei.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.